EP1804898A1 - Implantierbarer medizinischer situs - Google Patents

Implantierbarer medizinischer situs

Info

Publication number
EP1804898A1
EP1804898A1 EP05798603A EP05798603A EP1804898A1 EP 1804898 A1 EP1804898 A1 EP 1804898A1 EP 05798603 A EP05798603 A EP 05798603A EP 05798603 A EP05798603 A EP 05798603A EP 1804898 A1 EP1804898 A1 EP 1804898A1
Authority
EP
European Patent Office
Prior art keywords
chamber
face
screen
wall
hollow needle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05798603A
Other languages
English (en)
French (fr)
Inventor
Jean-François CHANTRIAUX
Marie-Pierre Marthe D. Chantriaux-De Wazieres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compagnie Europeenne dEtude et de Recherche de Dispositifs pour lImplantation par Laparoscopie SA
Original Assignee
Compagnie Europeenne dEtude et de Recherche de Dispositifs pour lImplantation par Laparoscopie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34959085&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP1804898(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Compagnie Europeenne dEtude et de Recherche de Dispositifs pour lImplantation par Laparoscopie SA filed Critical Compagnie Europeenne dEtude et de Recherche de Dispositifs pour lImplantation par Laparoscopie SA
Publication of EP1804898A1 publication Critical patent/EP1804898A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0208Subcutaneous access sites for injecting or removing fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/04Access sites having pierceable self-sealing members
    • A61M39/045Access sites having pierceable self-sealing members pre-slit to be pierced by blunt instrument
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0208Subcutaneous access sites for injecting or removing fluids
    • A61M2039/022Subcutaneous access sites for injecting or removing fluids being accessible from all sides, e.g. due to a cylindrically-shaped septum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/02Access sites
    • A61M39/0208Subcutaneous access sites for injecting or removing fluids
    • A61M2039/0226Subcutaneous access sites for injecting or removing fluids having means for protecting the interior of the access site from damage due to the insertion of a needle

Definitions

  • the present invention relates to the general technical field of devices intended to be introduced under the skin of a human or animal patient, to be subsequently stitched with a hollow needle, through the skin of the patient, in order to to introduce and / or remove substances from the body of the patient, by limiting repeated skin injuries in the same place.
  • Such devices are generally called implantable sites, or access ports.
  • the present invention more particularly relates to an implantable device for injecting and / or removing fluid either from an organ or vessel of the body of a human or animal patient, or from an inflatable and / or deflatable compartment of a surgical implant, said device comprising a housing within which is provided a chamber for connection to a catheter, said catheter being itself intended to be connected to said organ or vessel or to said compartment, the housing having a proximal wall and a distal wall between which extends a side wall, said housing comprising a puncture area designed to be pierced by a hollow needle for injecting and / or withdrawing fluid from the chamber.
  • Implantable sites are generally in the form of a housing having a bottom from which extend lateral walls whose free ends define a proximal opening.
  • the bottom and the side walls are made of a solid and rigid material, such as titanium, to prevent they can be pierced by a needle.
  • the proximal opening is closed by a substantially planar membrane of self-sealing material, thus forming a "septum".
  • the objects assigned to the invention therefore aim at proposing a new implantable injection and / or fluid sampling device making it possible to remedy the various disadvantages listed above and facilitating implantation and injection and / or implantation operations. regardless of the orientation of the device under the skin of the patient, without risk of injuring the patient with the needle.
  • Another object of the invention is to propose a new implantable injection and / or fluid sampling device that allows the practitioner to prick according to a gesture substantially similar to that used when pricking a natural vein.
  • Another object of the invention is to propose a novel implantable injection and / or fluid sampling device which reduces the risks and drawbacks associated with body movements performed by the patient.
  • Another object of the invention is to propose a novel implantable injection and / or fluid sampling device which does not need to be sutured to the body of the patient.
  • Another object of the invention is to propose a new implantable injection and / or fluid sampling device of particularly simple and compact design.
  • Another object of the invention is to propose a new implantable device for injecting and / or removing particularly light fluid.
  • Another object of the invention is to provide a new implantable device for injection and / or fluid sampling particularly safe.
  • the objects assigned to the invention are achieved by means of an implantable injection and / or fluid sampling device either in an organ or vessel of the body of a human or animal patient, or in an inflatable compartment and or deflating a surgical implant, said device comprising a housing in which is formed a chamber intended to be connected to a catheter, said catheter being itself intended to be connected to said body or vessel or to said compartment, the housing having a proximal wall and a distal wall between which a side wall extends, said housing comprising a puncture area adapted to be pierced by a hollow needle for injecting and / or withdrawing fluid from the chamber, characterized in that said puncture area is shaped to extend both at least at the proximal wall, the side wall and the distal wall, said device tif comprising a screen made of a material not pierceable by the hollow needle disposed within the chamber, to avoid drilling from one side of the
  • FIG. 1 illustrates, in a schematic perspective view, a first embodiment of a device according to the invention.
  • FIG. 2 illustrates, in a schematic perspective view, a second embodiment of a device according to the invention.
  • FIG. 3 illustrates, in a schematic perspective view, a third embodiment of a device according to the invention.
  • - Figure 4 illustrates, in a schematic perspective view, a fourth embodiment of a device according to the invention.
  • FIG. 5 illustrates, in a schematic perspective view, a fifth embodiment of a device according to the invention.
  • FIG. 6 illustrates, in a schematic longitudinal sectional view, a sixth embodiment of a device according to the invention.
  • FIG. 7 illustrates, in a schematic longitudinal sectional view, a seventh embodiment of a device according to the invention.
  • FIG. 8 illustrates, in a schematic cross-sectional view, a device according to one or the other of the sixth and seventh embodiments respectively illustrated in Figures 6 and 7.
  • FIG. 9 illustrates, in a schematic cross-sectional view, an eighth embodiment of a device according to the invention.
  • FIG. 10 illustrates, in a schematic perspective view, the internal structure of the device shown in Figure 2.
  • FIG. 11 illustrates, in a schematic side view, a ninth embodiment of a device according to the invention, forming an artificial vein.
  • Figure 12 illustrates, in a schematic cross-sectional view, the device shown in Figure 11.
  • FIG. 13 illustrates, in a schematic cross-sectional view, a tenth embodiment of a device according to the invention.
  • FIG. 14 illustrates, in a schematic cross-sectional view, an eleventh embodiment of a device according to the invention.
  • FIG. 15 illustrates, in a schematic cross-sectional view, a twelfth embodiment of a device according to the invention.
  • FIG. 16 illustrates, in a schematic cross-sectional view, a thirteenth embodiment of a device according to the invention.
  • FIG. 17 illustrates, in a schematic cross-sectional view, a fourteenth embodiment of a device according to the invention.
  • FIG. 18 illustrates, in a schematic cross-sectional view, a fifteenth embodiment of a device according to the invention.
  • FIG. 19 illustrates, in a schematic cross-sectional view, a sixteenth embodiment of a device according to the invention.
  • FIG. 20 illustrates, in a schematic cross-sectional view, a seventeenth embodiment of a device according to the invention.
  • FIG. 21 illustrates, in a schematic cross-sectional view, an eighteenth embodiment of a device according to the invention.
  • FIG. 22 illustrates, in a schematic view, the principle of operation of the screen equipping the device illustrated in FIG. 21.
  • FIG. 23 illustrates, in a schematic longitudinal sectional view, a nineteenth embodiment of a device according to the invention.
  • - Figure 24 illustrates, in a schematic partial side sectional view, a twentieth embodiment of a device according to the invention, the puncture area is being pierced by a hollow needle.
  • FIG. 25 illustrates, in a schematic cross-sectional view, the device of Figure 24, the hollow needle is not however shown.
  • FIG. 26 illustrates, in a schematic view in partial longitudinal section, a twenty-first embodiment of a device according to the invention.
  • the invention relates to an implantable device 1 for injection and / or fluid sampling.
  • a device which could also be referred to as "implantable site”
  • implantable site is intended to be implanted, for example surgically, in the body of a patient, and in particular under the skin of said patient, in order to constitute a access port for the introduction or extraction of fluids within the body of said patient, which may be human or animal.
  • the implantable device 1 according to the invention can be implemented and adapted for different uses.
  • the implantable device 1 according to the invention may be designed for the injection and / or the removal of fluid from an organ or vessel of the body of a patient, and in particular into the venous and / or arterial system. said patient.
  • the device 1 according to the invention allows the injection of drugs into a vein or artery.
  • the device 1 according to the invention may also be adapted to supply implanted reservoirs of the insulin pump or analgesic type.
  • the device 1 according to the invention is adapted to form an artificial vein (or artery), which the practitioner, doctor or nurse, can sting to the way of a natural vein to inject a drug substance or take blood.
  • the implantable device 1 may also be adapted for injecting and / or withdrawing fluid into an inflatable and / or deflatable compartment of a surgical implant, and in particular a gastroplasty ring intended for treatment. of obesity.
  • Such a gastric band is known per se, and is generally formed by a flexible band intended to be closed in a loop around the stomach substantially towards and by its two ends, with the aid of a closure system, to reduce the diameter of the opening of the stoma.
  • Said strip may comprise an annular compression chamber with adjustable volume, connected by a catheter to an implantable device 1 according to the invention, which allows the internal pressure of the chamber to be adjusted in order to adjust the diametrical expansion of the latter.
  • the device which is the subject of the present invention may, however, be used for the adjustment of other surgical implants, such as, for example, balloons or artificial sphincters.
  • hypodermic device that is to say intended to be positioned just under the skin of the patient. patient.
  • the device according to the invention may, however, be implanted at other locations in the body of the patient, and in a deeper way.
  • the device 1 comprises a housing 2 in which is formed a substantially sealed and sealed chamber 2A.
  • the chamber 2A which is delimited by a chamber wall 2B, thus defines an internal volume intended to receive a fluid to be injected and / or taken in the body of the patient.
  • Said chamber 2A is intended to be connected to a catheter 3, said catheter 3 being itself intended to be connected to either the organ or vessel 10 to which it is desired to inject or withdraw fluid (see FIG. inflatable / deflatable compartment of the surgical implant (not shown).
  • the housing 2 is provided with a guiding means for cooperating with a wire guide to facilitate the introduction of the device 1 under the skin of the patient.
  • the guide means (not shown) slidably cooperates with the guide wire, the latter being threaded into said guide means.
  • the guiding means is formed by a through tunnel formed in the housing 2, over and over the entire length of the latter, for example coaxially with the axis of symmetry of the housing 2.
  • the housing 2 may comprise a central tunnel for receiving the wire guide and around which is formed the chamber 2A, the latter then having an annular shape.
  • the housing 2 has a proximal wall 4 and an opposing distal wall 5, between which a side wall 6 extends.
  • proximal is meant in a conventional manner the wall intended to be situated immediately below the skin of the patient, once the device 1 implanted subcutaneously.
  • the housing 2 comprises, in a conventional manner, a puncture zone 7 designed to be pierced by a hollow needle 14, for injecting and / or withdrawing fluid from the chamber 2A.
  • the puncture zone 7 comprises a self-sealing membrane, made for example of elastomeric material, of the silicone type.
  • a membrane has "self-healing" properties. Thanks to these properties, the orifice generated by piercing the membrane with the aid of the needle 14 is automatically re-opened after extraction of the needle 14, which makes it possible to substantially maintain the tightness of the chamber 2A.
  • the puncture zone 7 is shaped so as to extend both at least on the proximal wall 4 and the side wall 6, that is to say that the puncture 7 substantially, at least in part, the contour of said proximal walls 4 and lateral 6.
  • the invention proposes a radically opposed concept, which consists in extending the puncture zone 7 to the side wall 6, so as to render unnecessary, or at least not essential, a fixation of the device 1 by suture.
  • the device 1 in the event of tilting, that is to say of change of orientation, for example under the effect of the movements of the patient, the device 1 according to the invention, the probability that the puncture zone 7 is more accessible is reduced, since said puncture zone 7 extends not only at the level of the proximal wall 4 as in the prior art, but also at the level of the side wall 6.
  • the puncture zone 7 is shaped so as to extend at least at least on the proximal wall 4, the side wall 6 and the distal wall 5, so as to constitute a quilting zone of sufficient size and conformation so that the housing 2 is "piquable" regardless of its angular orientation under the skin of the patient.
  • proximal walls 4, distal 5 and side 6 together contribute to form a substantially polyhedral surface.
  • the proximal 4, distal 5 and lateral 6 walls form a rectangular parallelepiped.
  • the side wall 6 is formed on the one hand of two parallel longitudinal panels 6A, 6B and on the other hand of two parallel transverse panels 6C, 6D, said transverse panels 6C, 6D extending in a substantially perpendicular direction to the direction in which the longitudinal panels 6A, 6B extend.
  • the catheter 3 is intended to be connected to the chamber 2A at one of the transverse panels 6C, 6D, via a conduit 3A connecting the chamber 2A to the outside of the device 1 and extending longitudinally substantially in the direction of the longitudinal panels 6A, 6B.
  • the catheter 3 is distinct from the conduit 3A and the housing 2.
  • the catheter 3 comes from material with the conduit 3A, so that it forms with the latter a single piece.
  • the housing 2 and the catheter 3 form a unitary assembly, the catheter 3 being integral with the chamber 2A by construction and not being intended to be disconnected from the housing 2.
  • the puncture zone 7 extends over most or even substantially all of the proximal walls 4, distal 5 and longitudinal panels 6A, 6B.
  • the transverse panels 6C, 6D may of course also constitute the puncture zone 7, although this is not really necessary, given the low risk of tilting of the device 1 around the transverse direction.
  • all the faces of the casing 2 shown in FIG. 1 can advantageously be used for the puncture, so that an accidental reversal (or simple change of orientation) of the site 1 would not entail any truly awkward consequence for the site. practitioner or patient.
  • FIGS. 2 to 8 the variants of FIGS. 2 to 8 will be described in greater detail.
  • the duct 3A which connects the chamber 2A to the outside of the device 1 and which is intended to be connected to the catheter 3, extends longitudinally along a first axis X -X '.
  • the conduit 3A may be provided with a coaxial bulge 30A (see FIGS. 6 and 7) with a diameter slightly greater than the nominal internal diameter of the catheter 3.
  • the catheter 3, which conventionally has a certain radial elasticity, is thus forced into force on the duct 3A and the bulge 30A, which ensures its maintenance.
  • the catheter 3 is surrounded, in the vicinity of the duct 3A,
  • a stiffening means 20 (see Figures 1 to 5), constituted for example by a tube or a helical wire 21, the spring kind. Way to • stiffening 20, which may also have flexibility in bending, avoids the accidental closure phenomena of the catheter 3 by folding of the latter.
  • the proximal walls 4, distal 5 and lateral walls 6 are shaped and arranged so that the housing 2 has substantially a symmetry with respect to a second axis Y-Y ', said second axis YY' being substantially parallel to the first axis X-X '.
  • the housing 2 thus has a symmetry of revolution about a second axis YY ', which extends substantially in the same direction as the conduit 3A for connecting the catheter 3.
  • a second axis YY ' which extends substantially in the same direction as the conduit 3A for connecting the catheter 3.
  • the proximal 4, distal 5 and lateral 6 walls together form a substantially spherical surface, as shown in FIG. 3.
  • the puncture zone 7 may extend substantially over the all of the proximal walls 4, distal 5 and lateral 6, that is to say on substantially the entire spherical surface.
  • the puncture zone 7 extends only over a central circular band of the spherical surface, said circular band being symmetrical relative to the second axis YY ', which is preferably coincident with the first axis X-X '.
  • the proximal walls 4, distal 5 and lateral 6 together contribute to form a substantially ovoidal surface, extending longitudinally along the axis YY ', in the same direction that the duct 3A.
  • Such an ovoid housing is particularly easy to introduce under the skin of the patient, and particularly well tolerated by the latter.
  • the puncture zone 7 of the ovoid casing of FIG. 2 can extend substantially over all the proximal walls 4, distal 5 and lateral walls 6, c '. that is to say on the whole of the ovoid surface. But it can also, and this configuration will be preferred, occupy only a central circular band of the ovoid surface, said circular band being symmetrical relative to the second axis YY '.
  • the proximal, distal and lateral walls 6 together form a substantially pear-shaped surface.
  • the conduit 3A for connection to the catheter 3 will be connected to the chamber 2A at the apex of the piriform surface.
  • the puncture zone 7 may extend substantially over all of the proximal walls 4, distal 5 and lateral 6, or simply occupy a portion of the piriform surface, and for example, as described for the previous variants, occupy a central circular band of axis of symmetry Y-Y '.
  • the proximal walls 4, distal 5 and side 6 contribute together to form a substantially cylindrical surface.
  • the puncture zone 7 may extend over substantially all of this cylindrical surface, or only a portion of said surface, in particular a central circular band.
  • the housing 2 corresponding to the embodiment illustrated in Figure 6 comprises a front ring 15 and a rear ring 16, positioned opposite and at a distance from one another, coaxially with the first and second axes X-X ' , Y-Y '. Between the rings 15, 16 is positioned a cylindrical sleeve 17, made of elastomeric material and which forms the puncture zone 7.
  • the conduit 3A is threaded into the front ring 15, centrally relative to the axis YY '.
  • the front and rear rings 15, 16 may optionally be mechanically connected by spacers (not shown), which would constrain longitudinally in compression the sleeve 17.
  • spacers not shown
  • the sleeve 17 would then be introduced in force between the two rings, which would create a compression of the elastomeric material according to the axis Y-Y ', which is confused in this case with the axis X-X'.
  • the casing 2 comprises only one distinct ring, namely the front ring 15, the rear ring being made of material with the sleeve 17.
  • the region of the sleeve 17 corresponding to the rear ring 16 is made of an elastomer material different from that in which the rest of the sleeve is made, and having for example a higher hardness.
  • the housing 2 may be formed of a frame 12 made of a material substantially not pierced by a needle 14, having a certain rigidity (cf. Figure 10).
  • the armature 12 is advantageously covered with an envelope (not shown) made of a self-sealing material, said armature 12 being perforated to form, in cooperation with said casing, the puncture zone 7. More particularly, the armature 12 is designed to give the casing 2 its general shape, in this case a form ovoid for the example shown in Figure 10.
  • This armature 12 serves as a support for an envelope in the form of a substantially elastic pocket, to be threaded, preferably in force, on the frame 12 and marry the general shape of the latter, like a sock.
  • the elastic bag is thus stretched over the armature 12.
  • the casing may advantageously comprise a membrane made of elastomeric material, of the biomedical silicone type.
  • the armature 12 is perforated, that is to say pierced, at least locally, a series of orifices of sufficient size to allow the needle 14 to pass through.
  • the latter after having first pierced the envelope, can thus reach the internal volume delimited by the armature 12 and corresponding to the chamber 2A.
  • the armature 12 is formed of a lattice of rigid material, as shown in FIG. 10.
  • This lattice may, for example, be made using titanium or stainless steel wires. or result from the molding of a plastic material.
  • housings 2 having a symmetry of revolution about the second axis YY ', itself parallel or coincident with the first axis X-X'.
  • the housing 2 has no true symmetry of revolution but is simply formed of a curved or left surface, for example of elliptical section, such as that is shown in Figure 9.
  • a screen 13 made of a material not pierced by the needle 14, is disposed within the chamber 2A, to avoid drilling from one side of the housing by the needle 14.
  • the screen 13 is designed to prevent the tip of the needle 14, once it is within the chamber 2A, to continue its course by piercing again the housing 2 and thus protrude out of the housing 2, in the body of the patient.
  • the screen 13 thus serves as a stop for the needle 14.
  • the screen 13 will in particular be designed according to the conformation of the puncture zone 7, so as to allow effective and safe stitching at any point in this zone. puncture 7.
  • the expression "disposed within the chamber” used in relation to the screen 13 must be understood in its most general sense.
  • the invention aims in particular implantable devices provided with a screen 13 which is embedded in the structure of the housing 2 and in particular in the chamber wall 2B, which is advantageously formed by the membrane forming the puncture zone 7.
  • the screen 13 comprises a finned wheel shaped and positioned so that the fins 13A, 13B, 13C, 13D extend substantially radially around the axis of symmetry YY 'of the housing 2.
  • said fins 13A, 13B, 13C, 13D extending radially from a central axis, which itself is preferably coaxial with the axis of symmetry of the housing 2.
  • the fins are at least four in number, regularly spaced angularly. It is of course conceivable to provide a lower or higher number of fins, or another type of screen 13.
  • the screen 13 is also preferably shaped to allow communication and fluid circulation within the chamber 2A.
  • the screen 13 is formed by a wheel with four flat fins 13A, 13B 1 13C, 13D
  • the four compartments defined in the chamber 2A, by said fins 13A , 13B, 13C, 13D will not be waterproof and will all be in fluid communication, even indirectly, with each other.
  • the screen 13 may float freely within the chamber 2A or possibly be held in position by means of an ad hoc fixing system.
  • Said fixing system may for example comprise centering shafts 13E, 13F (see FIG. 6) cooperating with complementary housings formed within the housing, so as to hold the finned wheel in position, while possibly allowing it to rotate around the Y-Y 'axis.
  • the finned wheel forming the screen 13 is rotatably mounted within the chamber 2A.
  • the finned wheel may preferably comprise a rotation shaft 13G, extending coaxially with the axis of symmetry of the housing 2 and the puncture zone 7, axis 13G from which extend two curved flaps 13H, 131 diametrically opposite relative to the axis 13G.
  • a rotation shaft 13G extending coaxially with the axis of symmetry of the housing 2 and the puncture zone 7, axis 13G from which extend two curved flaps 13H, 131 diametrically opposite relative to the axis 13G.
  • it may be implemented a number of curved flaps 13H, 131 greater than two, without departing from the scope of the invention.
  • the screen 13 advantageously comprises at least one abutment panel 18A-18G for the hollow needle 14, mounted slidingly against the chamber wall 2B 1 such that said panel 18A-18G can be moved within the chamber 2A under the effect of a thrust exerted by the hollow needle 14 towards the inside of the chamber 2A, during the puncture operation.
  • FIGS. 14 to 16 lies in the implementation of a "global" displacement of the screen 13, under the effect of the force exerted by the needle 14 when it abuts against the screen 13, the displacement of the latter being guided by sliding support of the panels 18A-18G on the wall 2B of the chamber 2A.
  • the screen 13 comprises two abutment panels 18A-18B preferably having a similar curved shape, said panels being symmetrically disposed in a substantially Y-shaped or V-shaped, each of the three ends of said Y or V being connected to a corresponding slider 19A-19C, said slider abutting sliding against the wall 2B of the chamber 2A.
  • the panels 18A, 18B and their associated pads 19A-19C thus form a unitary assembly guided in rotation within the chamber 2A.
  • the displacement of the screen 13 according to variant 14 is thus controlled and can only be performed according to one or more predetermined degrees of freedom.
  • the invention is of course not limited to a V-shaped or Y-shaped screen, and the panel or panels may for example form an S (see panel 18C of FIG. or a W (see panel 18D, 18E, 18F, 18G of FIG. 16).
  • the screen 13 is preferably formed of a single panel 18C doubly curved to form an S, each of the ends of the S being provided with a sliding shoe 19D, 19E corresponding, bearing on the wall 2B.
  • the screen 13 is formed of four planar panels 18D, 18E, 18F, 18G interconnected accordion to form a W, each of the vertices W being provided with a corresponding slider 19F- 19J designed to slide against and along the wall 2B of the chamber 2A.
  • FIGS. 14 to 16 is not limited to a particular number or shape of a panel, nor to a specific number or shape of slider, which may have a rounded shape. as is the case in the variants of Figures 15 and 16, or rather a spatula shape, as is the case in the variant of Figure 14.
  • the panels 18A-18G preferably have a substantially rigid character, and are designed so that the needle 14 can obviously not pierce them.
  • the screen 13 comprises at least one abutment panel 18H-18O for the hollow needle 14, preferably arranged opposite and in the vicinity of the chamber wall 2B, said at least one 18H-18O panel being deformable under the effect of a thrust exerted by the hollow needle 14.
  • the panels constituting the screen 13 do not move under the effect of the support exerted by the hollow needle (as was the case in the variant previously described), but deform under the effect of this support.
  • the screen 13 may comprise four 18H-18K panels affixed relative to each other to cover the entire wall surface 2B that may be pierced by the needle. 14.
  • each panel has substantially in cross section, a quarter-circle profile, so that the combination of the four panels has a substantially circular contour, corresponding to the circular contour of the chamber section 2A.
  • each panel 18H-18K is deformable in flexion.
  • the panels 18H-18O work in another mode of deformation, for example in compression or traction.
  • each panel 18H-18O comprises a plurality of substantially rigid unit elements interconnected by flexible links to form the panel.
  • the deformation of the panel is not obtained by the intrinsic deformation characteristic of the material forming the panel, but by displacement of the rigid unit elements.
  • the panels 18L-18O may have a curved preform towards the inside of the chamber 2A. It is also quite possible, as illustrated in FIG. 17, for the screen 13 to be freely disposed within the chamber 2A, or on the contrary that it be fastened locally to the wall 2B of said chamber 2A. as shown in Figure 18.
  • each panel is fixed to the wall 2B of the chamber 2A via two associated fastening lines 20A-20D, each fastening line 20A-20D being common to two panels, in the case where four panels are implemented, as shown in Figure 18.
  • the screen 13 comprises a flexible membrane 21 whose shape is substantially conjugate to that of the chamber wall 2B 1, said membrane 21 being freely disposed within the chamber 2A and being deformable under the effect of a thrust exerted by the hollow needle 14.
  • the membrane 21 also has a substantially ovoid conjugate shape, which substantially matches the contour of the wall 2B.
  • said membrane 21 may delimit a closed volume, and in this case forms a flexible pouch.
  • the membrane 21 is made of a flexible and flexible material, but strong enough not to be pierced by the needle 14.
  • the membrane 21 has a shape memory, that is to say that it is designed to find automatically and without external stress its normal configuration in which its shape is substantially conjugated to that of the wall 2B, after it has been deformed by the thrust exerted by the needle 14.
  • the membrane 21 is made by weaving a substantially rigid material, such as a metal or a hard plastic for example.
  • the membrane 21 consists of a chain of metal mesh, the mesh size being chosen to prevent the passage of a hollow needle 14.
  • the membrane 21 floats freely within the chamber 2A, that is to say that it is not constrained in a predetermined position.
  • said membrane 21 has a character sufficiently porous to allow the circulation of fluid throughout the chamber 2A.
  • the membrane 21 has an impermeable character and is attached to the wall 2B 1 without departing from the scope of the invention.
  • the screen 13 advantageously comprises a plurality of particulate elements 22 freely disposed within the chamber 2A, said particulate elements 22 being sufficient in number for the introduction of the hollow needle 14 in the chamber 2A generates, at least locally, the mutual blocking of the particulate elements 22, which thus form together a stop for the needle 14, stopping the latter in its progression.
  • the number of particulate elements 22 is chosen so that said particulate elements occupy substantially all of the available volume in the chamber 2A, except for a fraction of volume corresponding approximately to the volume of the chamber. needle 14.
  • each particulate element 22 can move with a certain degree of mobility, whereas when the needle 14 is introduced into the chamber 2A, substantially all of the available volume of the chamber 2A is occupied, which has the effect of locking in position relative to each other the particulate elements 22, which thus prevent any progression of the needle 14 which could lead to a piercing through and through the puncture zone 7.
  • the particulate elements 22 have substantially a spherical shape, it being understood that the invention is not limited to a specific form of particulate elements, which could also be polygonal, for example.
  • the particulate elements 22 are made of a rigid and resistant material, such as a hard plastic or a metal.
  • the screen 13 has a first face 23 disposed opposite the chamber wall 2B and a second opposite face 24.
  • Said first face 23 is provided with access means 25 allowing the hollow needle 14 to pass through the screen 13 in the direction of the first face 23 towards the second face 24, so that the hollow needle 14 can completely cross the screen 13, while the second face 24 is provided with locking means 26 to prevent the needle 14 to pass through the screen 13 in the direction of the second face 24 to the first face 23 .
  • the screen 13 of the embodiments shown in Figures 20 to 26 is pierced exclusively in a single direction, from its outer face to its inner face.
  • the needle 14 may completely completely pass through one of the two screen portions 130 in the direction of its first face 23 towards its second face 24, but will be blocked against the second face 24 of FIG. the second portion 131 of screen 13, since said second face 24 is provided with locking means preventing the needle 14 from passing through the screen 13 in the direction of the second face 24 towards the first face 23.
  • This embodiment is therefore particularly well suited to a puncture zone 7 extending 360 ° on the housing 2, since it is sufficient in this case to line the inner wall 2B of the chamber 2A with the screen 13 (cf. Figure 21) to obtain the desired "smart shield" effect.
  • the invention corresponding to the embodiment of Figures 20 to 26 is based on a partial piercing of the screen 13, said screen 13 being provided with a first face 23 pierceable and a second face 24 opposite non-pierceable.
  • the screen 13 advantageously comprises a series of unitary elements 27 arranged side by side and resiliently biased against each other.
  • the elements 27 thus together form an elastically deformable sheet.
  • the unit elements 27 are each made of a sufficiently strong material not to be pierced by the needle 14.
  • each unit element 27 preferably has a rigid character.
  • the unit elements 27 cooperate to define between each of them, and opposite the chamber wall 2B, a corresponding convergent path 27A for the hollow needle 14, so that the insertion of the hollow needle 14 into a Convergent path 27A will lead, as illustrated in Figure 22, to the relative spacing of the corresponding elements 27, thus allowing the passage of the needle 14 to and into the chamber 2A.
  • the set of convergent paths 27A thus form the first face 23 of the screen 13, that is to say the face allowing insertion and passage of the needle 14.
  • the elements 27 also cooperate to define between each of them, opposite the convergent path 27A, an obstacle 27B to the passage of the needle 14 between them.
  • the set of obstacles 27B thus forms the second face 23, second face 23 which substantially prevents any penetration of the needle 14 into and through the screen 13.
  • the unit elements 27 have a substantially triangular shape in cross section and are elastically connected together to form a circular base cylindrical sheet, conjugated to the cylindrical shape of the wall chamber 2B, wall 2B in which extends continuously the puncture zone 7.
  • Each unit element 27 of triangular section has, in cross section, a base from the ends of which extend two sides joining in a vertex.
  • the triangular elements 27 are elastically connected to each other so that the bases of each of the elements 27 are in continuity with each other, and thus form a substantially smooth and uniform surface.
  • This smooth and uniform surface constitutes the second face 24, second face 24 which by its smooth and solid character does not allow the needle 14 to clear a passage between the triangular elements 27.
  • the sides of the triangles extending from the base define two by two interstitial spaces of substantially triangular shape in cross section, each interstitial space converging towards the interior of the chamber 2A.
  • the needle 14 can not, however, pierce the membrane 7 again, since it will be stopped in the path by the second face 24, as shown in FIG. 22.
  • the base of each triangle will have a conformation to improve the obstacle effect of the second face 24.
  • each member 27 may include a lug 27B at one end thereof; that the other end has an evident 27C of complementary shape to that of the pin 27B, so as to make a nesting of the triangular elements 27 in each other.
  • Such an engagement, illustrated in FIG. 22, increases the reliability of the obstacle function provided by the second face 24.
  • the screen 13 comprises a plurality of tubular elements 28 each having a substantially convergent shape , said elements 28 are preferably all substantially identical and made of a material not pierceable by the hollow needle 14, preferably substantially rigid.
  • the elements 28 are threaded into each other, so as to form a substantially tubular structure having an outer face, forming the first face 23, and an inner face, forming the second face 24.
  • each element 28 is in the form of a frustoconical ring.
  • the elements 28 are held in position relative to each other by means of a connecting wire 29, for example in the form of a flexible cord, fastened to each element 28.
  • the stack of elements 28 is freely disposed within the chamber 2A, the dimensions of the stack being chosen, however, relative to those of the chamber 2A so that said stack is substantially adjusted within of the chamber 2A, and can take only an orientation coaxial with that of said chamber.
  • tubular elements 28 are fixed in position within the chamber 2A, for example being connected to the end piece 3A intended to be connected to the catheter 3.
  • the membrane 7 forming the chamber wall 2B is directly overmolded on the stack of tubular elements 28, or simply bonded by bonding to said stack.
  • tubular sleeve 30 disposed within the chamber 2A coaxially with the latter, the elements 28 being threaded and held onto said tubular sleeve 30, which may be preferably made of a material pierced by the hollow needle, such as silicone.
  • the needle 14 then passes through the sleeve 30 (if such a sleeve is provided) and arrives within the chamber 2A, which then makes it possible to perform the desired operation of injection or aspiration of fluid.
  • the needle 14 continues its course, it would abut against the face 24, in an orientation preventing the needle from passing beyond the screen 13 and pierce the membrane 7.
  • the stitching direction of the needle 14 is controlled by the convergent orientation of the elements 28, convergent orientation which forces the needle 14 to adopt an oblique path, substantially parallel, with the clearance, to the conformation of the elements 28.
  • the stitching orientation of the needle 14, controlled by the first face 23 prevents said needle 14 from sliding in an interstitial interstitial space 28 at the level of the second face 24, since the interstitial interstitial spaces of the second face 24 have an orientation which is symmetrical to that of the orientation of the needle 14 relative to the axis of symmetry of the chamber 2A.
  • the invention is not limited to the implementation of tubular elements, but more generally aims at the implementation of two oblique stacks of blades arranged symmetrically within the chamber 2A, the first stack forming the face 23 and allowing the passage of the needle 14 in a predetermined oblique direction, while the second stack is blocking the trajectory of the needle.
  • the invention is therefore based, as far as this embodiment is concerned, on the internal (or internal) lining of the puncture zone 7 by a series of scales, said scales allowing the passage of the needle exclusively in one direction. predetermined.
  • the screen 13 advantageously comprises a plurality of lamellae 31 arranged so as to partially overlap each other, in substantially a tubular outline having an external face, forming the first face 24, and an inner face forming the second face 23.
  • the general technical principle underlying this embodiment is similar, or at least very similar, to that implemented in the variants of FIGS. 23 to 25, since it is again based on the realization of a system with scales, said scales being in this case formed by lamellae substantially not pierceable by the hollow needle 14.
  • Said lamellae are preferably rigid, and for example made of a metal of the steel or titanium type.
  • each lamella 31 will advantageously consist of a foil ribbon.
  • the slats 31 are arranged so as to partially overlap each other, so as to define, as in the variants of Figures 23 and 24, a passage path for the needle 14, in a predetermined oblique direction, direction incompatible with the penetration by the needle of the second face 24.
  • the screen 13 of the previously described variants illustrated in particular in FIGS. 17, 18 and 20 to 26 to be integrated wholly or partly directly within the chamber wall 2B.
  • the elements forming the screen 13 are advantageously embedded in the structure of the wall 2B, which is preferably directly formed by the "septum" membrane forming the puncture zone 7.
  • Technical measure may in particular be used to maintain in position relative to each other the elements forming the screen 13, without additional means, such as the rope 29 or the sleeve 30, is necessary.
  • said elements will be embedded at a distance from the surface of the wall 2B sufficiently small so that when the hollow needle 14 is in abutment against the screen 13, its internal orifice, which classically debouches beveled at the tip of the needle, is not closed and opens into the chamber 2A.
  • FIGS. 11 and 12 The embodiment shown in FIGS. 11 and 12 will now be described in greater detail, and which concerns a hypodermic device 1 for injecting a drug into a vein 11 (or artery) and / or collecting blood in said vein 11 (or artery), said device 1 thus forming a vein or artificial artery.
  • the device 1 aims to faithfully mimic a natural vein, in order to substitute it for intravenous injection of medical products or blood collection operations.
  • the device 1 substantially reproduces the geometry of a portion of natural vein, that is to say that it is in the form of an elongated tubular housing, made for example integrally of a pierceable material, like silicone.
  • the device 1 thus constituted is intended to be flush with the skin of the patient, above the vein 11 to which it is connected.
  • the device 1 according to this embodiment is intended to be stitched in the manner of a natural vein, that is to say at a grazing angle relative to the skin of the patient, and not perpendicularly, as in the case of stitching of a site of the prior art.
  • Such a "tangential" stitching does not fundamentally necessitate the presence of a screen 13.
  • a screen may be considered, as is the case for the variant of Figures 11 and 12.
  • the distal wall 5 is substantially planar and is delimited laterally by two lateral edges 5A, 5B, while the proximal wall 4 and the lateral wall 6 together form a surface of revolution, for example a semicircular, connecting said side edges 5A, 5B.
  • the screen 13 is in turn consists of a gutter, made of a material not pierced by the needle 14, but preferably having a flexible character.
  • Said gutter advantageously has a cross-section in "U”, the soul of the "U”, resting in the chamber 2A on the distal wall 5, while the arms of the "U” rise against the side wall 6.
  • the housing 2 may advantageously have a radio-opaque character, by the inclusion, in its internal structure, in a uniform manner or not, of a suitable marking substance.
  • the invention finds its industrial application in the production and use of implantable sites for injection and / or fluid sampling.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Prostheses (AREA)
EP05798603A 2004-08-19 2005-08-18 Implantierbarer medizinischer situs Withdrawn EP1804898A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR2004/002161 WO2006027425A1 (fr) 2004-08-19 2004-08-19 Site medical implantable
PCT/FR2005/002104 WO2006021695A1 (fr) 2004-08-19 2005-08-18 Site medical implantable

Publications (1)

Publication Number Publication Date
EP1804898A1 true EP1804898A1 (de) 2007-07-11

Family

ID=34959085

Family Applications (2)

Application Number Title Priority Date Filing Date
EP04786327A Withdrawn EP1796780A1 (de) 2004-08-19 2004-08-19 Implantierbarer medizinischer situs
EP05798603A Withdrawn EP1804898A1 (de) 2004-08-19 2005-08-18 Implantierbarer medizinischer situs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP04786327A Withdrawn EP1796780A1 (de) 2004-08-19 2004-08-19 Implantierbarer medizinischer situs

Country Status (8)

Country Link
US (2) US8088112B2 (de)
EP (2) EP1796780A1 (de)
CN (1) CN101014382A (de)
AU (1) AU2004323123A1 (de)
BR (1) BRPI0419150A (de)
CA (1) CA2577614A1 (de)
MX (1) MX2007001991A (de)
WO (2) WO2006027425A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2904563B1 (fr) * 2006-08-03 2009-04-17 Cie Euro Etude Rech Paroscopie Site implantable lineaire compact
FR2913203B1 (fr) * 2007-03-01 2009-05-15 Cie Euro Etude Rech Paroscopie Site implantable a deflecteurs multiples
FR2914561B1 (fr) * 2007-04-05 2009-07-10 Cie Euro Etude Rech Paroscopie Site implantable avec ecran a cames
WO2008029010A1 (fr) * 2006-09-08 2008-03-13 Compagnie Europeenne D'etude Et De Recherche De Dispositifs Pour L'implantation Par Laparoscopie Site implantable avec septum multifacette
FR2914560B1 (fr) * 2007-04-05 2009-12-11 Cie Euro Etude Rech Paroscopie Site implantable avec volets basculants
FR2916980A1 (fr) * 2007-06-07 2008-12-12 Cie Euro Etude Rech Paroscopie Site implantable avec ecran a redistribution d'acces
FR2928275B1 (fr) * 2008-03-06 2010-12-24 Compagnie Europeenne Detude Et De Rech De Dispositifs Pour Limplantation Par Laparoscopie Site implantable avec ecran penetrant dans le septum
US9023063B2 (en) 2008-04-17 2015-05-05 Apollo Endosurgery, Inc. Implantable access port device having a safety cap
EP2471572A3 (de) 2008-04-17 2012-10-17 Allergan, Inc. Implantierbare Injektionsportvorrichtung
FR2935904B1 (fr) * 2008-09-18 2010-09-24 Cie Euro Etude Rech Paroscopie Site implantable avec septum a pre-contrainte bidirectionnelle
FR2935903B1 (fr) * 2008-09-18 2010-09-24 Cie Euro Etude Rech Paroscopie Site implantable avec boitier multi-perfore
US8715158B2 (en) 2009-08-26 2014-05-06 Apollo Endosurgery, Inc. Implantable bottom exit port
US8708979B2 (en) 2009-08-26 2014-04-29 Apollo Endosurgery, Inc. Implantable coupling device
US8506532B2 (en) 2009-08-26 2013-08-13 Allergan, Inc. System including access port and applicator tool
US9874158B2 (en) 2009-09-04 2018-01-23 Lg Fuel Cell Systems, Inc Engine systems and methods of operating an engine
US20110196195A1 (en) * 2010-02-05 2011-08-11 Allergan, Inc. Implantable subcutaneous access port
US8882728B2 (en) 2010-02-10 2014-11-11 Apollo Endosurgery, Inc. Implantable injection port
US8992415B2 (en) 2010-04-30 2015-03-31 Apollo Endosurgery, Inc. Implantable device to protect tubing from puncture
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
US20110270021A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Electronically enhanced access port for a fluid filled implant
US20120041258A1 (en) 2010-08-16 2012-02-16 Allergan, Inc. Implantable access port system
JP5706113B2 (ja) * 2010-08-26 2015-04-22 日本コヴィディエン株式会社 皮下埋込ポートの製造方法
US20120065460A1 (en) 2010-09-14 2012-03-15 Greg Nitka Implantable access port system
WO2012034193A1 (en) * 2010-09-17 2012-03-22 Christopher John Couch Conical port
US8920390B2 (en) * 2011-03-19 2014-12-30 Michael J. Dalton Vascular access port with tubular shaped septum
US8821373B2 (en) 2011-05-10 2014-09-02 Apollo Endosurgery, Inc. Directionless (orientation independent) needle injection port
US8858514B2 (en) * 2011-06-14 2014-10-14 Pierre Sarradon Internal device for injection and sampling of a liquid inside a living organism
US8801597B2 (en) 2011-08-25 2014-08-12 Apollo Endosurgery, Inc. Implantable access port with mesh attachment rivets
US9199069B2 (en) 2011-10-20 2015-12-01 Apollo Endosurgery, Inc. Implantable injection port
US8858421B2 (en) 2011-11-15 2014-10-14 Apollo Endosurgery, Inc. Interior needle stick guard stems for tubes
US9089395B2 (en) 2011-11-16 2015-07-28 Appolo Endosurgery, Inc. Pre-loaded septum for use with an access port
ES2973834T3 (es) * 2013-04-13 2024-06-24 Solinas Medical Inc Dispositivos de cierre automático, y aparato y métodos para fabricarlos y suministrarlos
FR3104406B1 (fr) * 2019-12-16 2022-10-14 Uromems Procédé de purge d’un dispositif médical adapté pour être implanté

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543088A (en) * 1983-11-07 1985-09-24 American Hospital Supply Corporation Self-sealing subcutaneous injection site
US4778452A (en) * 1985-12-16 1988-10-18 Surgical Engineering Associates, Inc. Implantable infusion port
US4710174A (en) 1985-12-16 1987-12-01 Surgical Engineering Associates, Inc. Implantable infusion port
US4802885A (en) * 1986-06-17 1989-02-07 Medical Engineering Corporation Self sealing subcutaneous infusion and withdrawal device
US4832054A (en) * 1986-07-07 1989-05-23 Medical Engineering Corporation Septum
US4817637A (en) * 1987-11-25 1989-04-04 Medical Engineering Corporation Subcutaneous injection and withdrawal site
US4857053A (en) * 1988-08-29 1989-08-15 Dalton Michael J Matrix septum
US5352204A (en) * 1990-03-01 1994-10-04 Ensminger William D Implantable access devices
FR2740977A1 (fr) * 1995-11-13 1997-05-16 Mazzella Gilbert Chambre implantable pour acces a une forme anatomique par voie transcutanee
US5778452A (en) * 1997-04-25 1998-07-14 Dicker; Timothy P. Exercise garment
US6471689B1 (en) 1999-08-16 2002-10-29 Thomas Jefferson University Implantable drug delivery catheter system with capillary interface
FR2802407B1 (fr) * 1999-12-21 2002-12-13 Rc Medical Anneau de gastroplastie desserrable
US6960185B2 (en) * 2000-04-14 2005-11-01 Alphaport, Llc Subcutaneous access port
US7776029B2 (en) 2001-01-30 2010-08-17 The Alfred E. Mann Foundation For Scientific Research Microminiature infusion pump
FR2851168B1 (fr) * 2003-02-13 2006-12-22 Jean Francois Chantriaux Site d'injection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006021695A1 *

Also Published As

Publication number Publication date
CN101014382A (zh) 2007-08-08
US8088112B2 (en) 2012-01-03
AU2004323123A1 (en) 2006-03-16
EP1796780A1 (de) 2007-06-20
US20080119798A1 (en) 2008-05-22
US20080039772A1 (en) 2008-02-14
BRPI0419150A (pt) 2007-12-11
CA2577614A1 (en) 2006-03-16
WO2006027425A1 (fr) 2006-03-16
MX2007001991A (es) 2007-07-16
WO2006021695A1 (fr) 2006-03-02

Similar Documents

Publication Publication Date Title
EP1804898A1 (de) Implantierbarer medizinischer situs
EP1827566A1 (de) Medizinischer situs, der in einen mehrschichtigen punktierten bereich implantiert werden kann
FR2916980A1 (fr) Site implantable avec ecran a redistribution d'acces
EP1108400A1 (de) Abnehmbare Befestigungsvorrichtung für eine Prothese bestimmt für ein Körpergefäss
FR2742665A1 (fr) Catheter a soupape a fente(s) axiale(s) bi-directionnelle(s)
WO2004087250A1 (fr) Dispositif de fixation au corps d’un patient d’un catheter
FR2533443A1 (fr) Stylet perfectionne pour tube d'alimentation
EP1957146A1 (de) Implantierbarer atraumatischer medizinischer situs mit vereinfachtem design
EP2077887A2 (de) Kompakte lineare implantierbare stelle
FR2851168A1 (fr) Site d'injection
FR2533442A1 (fr) Dispositif enterique pour administrer des fluides a un patient ou pour les aspirer
FR2940914A1 (fr) Dispositif pour l'administration locale d'un fluide chez un patient.
EP2765960B1 (de) Aufblasbares und einstellbares magenband zur behandlung von adipositas
WO2008003862A2 (fr) Ceinture gastrique preformee en « c »
WO2010031811A1 (fr) Site implantable avec boîtier multi-perforé
WO2008129165A1 (fr) Site implantable a deflecteurs multiples
WO2010061143A1 (fr) Dispositif permettant la fixation au corps d'un patient d'au moins une tubulure, telle qu'une tubulure de catheter ou un drain
WO2008029034A2 (fr) Site implantable a obturateur mobile
FR2903297A1 (fr) Ceinture gastrique preformee en "c"
WO2008029010A1 (fr) Site implantable avec septum multifacette
FR2907017A1 (fr) Site implantable avec embase amovible
FR3129841A1 (fr) Ensemble d’aiguille médicale de sécurité
FR2928275A1 (fr) Site implantable avec ecran penetrant dans le septum
FR2945452A1 (fr) Dispositif interne d'injection et de prelevement d'un liquide a l'interieur d'un organisme vivant
WO2009136122A2 (fr) Anneau chirurgical implantable a boyau monobloc

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070316

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20090707

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20091118